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Abstract
Practice Problem: Human Immunodeficiency Virus (HIV) is one of the leading pandemics in
the world. In 2019, 38 million people were living with HIV around the world. Of those, roughly
87% were aware of their HIV status.

PICOT: In patients with high risk for HIV, how does implementing a pre-exposure (PrEP)
screening tool compared to randomly screening for pre-exposure prophylaxis (PrEP) affect the
prescribing of pre-exposure prophylaxis (PrEP) within eight weeks?

Evidence: In 2015, the World Health Organization (WHO) recommended PrEP for the
prevention of HIV in high-risk individuals. The patients include men who have sex with men,
sex workers, individuals with multiple sex partners, and intravenous drug users. In 2021, only
about 25% of individuals with high-risk for HIV are utilizing PrEP.
Intervention: There are two interventions in this research: PrEP screening tool and prescription
of PrEP.

Outcome: An increase in the number of those screened for the use of PrEP increased
dramatically from previous screening. Although the percentage goal of those prescribed PrEP
was not met, there was an increase in those prescribed PrEP compared to previous prescribing
methods.

Conclusion: In conclusion, the use of a PrEP screening tool in general practice can increase the
use of PrEP in high-risk populations. The best way to stop the HIV pandemic is to utilize the best
prevention available, which is PrEP. Using a PrEP screening tool in clinics not knowledgeable
on PrEP will increase the prescribing of PrEP.
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Increasing the Prescribing of Pre-Exposure Prophylaxis
(PrEP) With a Pre-Exposure Prophylaxis Screening Tool
Human immunodeficiency virus (HIV) is a virus that has been classified as a global
pandemic for many decades. Millions of people across the world have been affected by HIV,
with millions dying from complications from the disease. Increasing the use of pre-exposure
prophylaxis (PrEP) is a way to decrease the spread of HIV. Initiatives to combat this pandemic
have been supported and discovered by world leaders and organizations, such as the use of PrEP
to prevent HIV. PrEP is a medication that has been around for years; however no clear focus has
been implemented to increase its usage on high-risk patients. Patients who are high risk for HIV
are men who have sex with men, sex workers, individuals with multiple sex partners, and
intravenous drug users. Nearly 14% of HIV positive patients were unaware of their HIV status
(HIV.gov, 2020). Prevention, along with adequate screening, is imperative in decreasing that
percentage. Implementing a PrEP screening tool will standardize screening to increase
prescription of PrEP to high-risk patients.
Significance of the Practice Problem
Human immunodeficiency virus (HIV) is a virus that attacks the body’s immune system
and, if left untreated, can lead to acquired immunodeficiency syndrome (AIDS). HIV started,
possibly as early as the 1800s, when the virus was spread from chimpanzees to humans then
spread across Africa and eventually across the world where it was initially seen in the United
States in the 1970s (Centers for Disease Control and Prevention, 2021). HIV is transmitted by
sexual contact, intravenous drug use, from mother to baby (during pregnancy, birth, and
breastfeeding), and by contact with blood/body fluids. In 2019, 38 million people globally were
living with HIV, with 1.7 million people becoming newly infected in the same year. Since the
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start of the pandemic, 32.7 million people have died from AIDS, with 690,000 people dying
from AIDS in 2019. Roughly 87% of people currently living with HIV knew about their HIV
status (UNAIDS, 2020). According to the CDC (2021), the lifetime cost of treating one patient
was roughly $485,000. There were 10,000 fewer new cases of HIV in 2008-2017, which
prevented an additional 100,000 cases of HIV because there were fewer undetected HIV patients
to spread the infection. This saved roughly $4.6 million in healthcare costs (CDC, 2021). Not
only is there a financial burden on the healthcare system and society, but there are also negative
impacts on the whole family. According to Ji et al. (2007), children of HIV patients often have
psychosocial stress, absent or ill parent(s), financial deprivation, stigma of the illness, and
discrimination. Relationships between couples can deteriorate when illness affects a person’s
ability to work and causes financial constraint which can result in anger, guilt, and resentment (Ji
et al., 2007).
According to the Kaiser Family Foundation (KFF; 2022), pre-exposure prophylaxis
(PrEP) has been shown to be effective in the prevention of HIV, with 99% effectiveness in
preventing the spread of HIV during sex and 74% effectiveness in preventing HIV during IV
drug use. PrEP is a daily medication, or more recently a monthly injectable, that is taken to
prevent patients from contracting HIV. In 2015, PrEP was recommended for HIV prevention by
the World Health Organization (WHO). A year later. PrEP research and development was
declared to be accelerated by the United Nations (KFF, 2022). Along with condoms, PrEP is key
prevention strategy to prevent HIV in high-risk patients, however only 25% of high-risk patients
are using the medication. The current initiative is to have 50% of patients with high-risk for HIV
use the medication by 2030 (CDC, 2021). Implementing a screening tool for PrEP will increase
those screened as well as those prescribed PrEP, beginning the prevention of HIV.

PRE-EXPOSURE PROPHYLAXIS (PREP) SCREENING TOOL

6

PICOT Question
Decreasing the spread of HIV is a worldwide goal; however, interventions are needed to
increase utilization of preventative medication that have been readily available for years. In
patients with high risk for HIV, how does implementing a pre-exposure prophylaxis (PrEP)
screening tool compared to randomly screening for pre-exposure prophylaxis (PrEP) affect the
prescribing of pre-exposure prophylaxis (PrEP) within eight weeks? The population of patients
that were included in this evidence-based practice change project were adult patients (18 and
older) who are high risk for HIV. Patients with high risk for HIV are men who have sex with
men, sex workers, intravenous drug users, and patients with multiple sex partners. Race and
gender are not significant for this population. Although it is recommended by the CDC that all
patients from the age of 13-64 receive HIV screening at least once in their lifetime, this practice
change focused on patients over the age of 18 (CDC, 2021). According to Minority HIV/AIDS
Fund (MHAF; 2021), adults aged 24-45 had the highest percentage of HIV positive patients, but
45% of those were unaware of their status (MHAF, 2021).
The intervention was implementation of a pre-exposure prophylaxis (PrEP) screening
tool. Pre-exposure prophylaxis is a medication taken daily to prevent HIV if a person should
have exposure to HIV. If taken appropriately, this medication is 99% effective in reducing the
contraction of HIV in sexual encounters and 74% effective in intravenous drug use encounters
(CDC, 2021). A PrEP screening tool was a questionnaire that was given to patients identified as
high risk for HIV to fill out while waiting for the provider. If the questionnaire was positive,
the provider screened for the use of PrEP. PrEP screening tools have been formulated and
utilized to determine PrEP eligibility. The comparison was randomly screening for PrEP. The
previous screening was randomly checked if patients were interested in PrEP or prescribed PrEP
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to patients who specifically asked for it. Most of these patients were men who have sex with
men and no other population of patient.
The outcome was concluded through data that was collected before and after intervention
implementation. The statistical testing used was the independent samples t-test, which is a
technique used to determine the difference between two independent groups (Grove & Cipher,
2020). The time frame of this practice change was eight weeks, which was a reasonable time
frame to see change.
Evidence-Based Practice Framework & Change Theory
The Johns Hopkins Nursing Evidence-Based Practice (JHEBP) framework was a threestep guide to assist the nurse with the practice question, evidence, and translation of best practice
into patient care (Dang et al., 2022). The initial inquiry was about preventing the spread of HIV
by utilizing PrEP, which is a very effective prevention method. Increasing the use of PrEP was
the concern. The DNP student determined a proper practice question and found evidence-based
research already available to translate into practice. Once practice improvement was deemed
successful, the team reflected on the success and determined how to apply it to the entire
organization. There are several tools that were associated with this framework to assist in
implementing a PrEP screening tool. The JHEBP framework tools helped with writing a proper
practice question, communication regarding stakeholders, research, and publication (Dang et al.,
2022). As this practice project moved through each process, the JHEBP framework guided the
work that was completed.
The change theory that was utilized in this project was Ronald Havelock’s model of
change. Havelock’s change theory consists of six phases: building a relationship, diagnosing the
problem, acquiring resources for change, selecting a solution pathway, establishing and
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accepting change, and maintenance (Wagner, 2018). The first step, building a relationship, was
the step that determined a change that was needed, which was increasing the prescription of
PrEP. The second step, diagnosing the problem, was deciding if a change was needed. This has
already been determined because PrEP has been extremely successful at decreasing the spread of
HIV, but utilization needed to be increased. The third stage, acquiring resources, was the start of
developing, or brainstorming, a solution to make changes. The solution was the PrEP screening
tool. The fourth stage, pathway solution, was the implementation of the change plan. In this
step, the DNP student provided staff education to help move into step five, establishing and
accepting change, so there was not resistance to change. Once the screening tool was determined
successful, the sixth stage, maintenance, will take place and can be properly implemented
throughout the organization (Wagner, 2018).
Evidence Search Strategy
The DNP student found numerous research articles during the initial search. Many of
them did not completely support the PICOT question, however several did. Databases utilized
include Google Scholars and the University of St. Augustine for Health Sciences (USAHS)
library, which included EBSCOhost, PubMed, ProQuest, and CINAHL. Key words in the
literature search were PrEP screening tool, Pre-exposure prophylaxis screening tool, PrEP tool to
increase PrEP prescribing, increasing PrEP usage, increasing PrEP prescribing, strategies for
prescribing PrEP, PrEP criteria for prescribing. Filters included peer review articles between the
years of 2015-2022. Inclusion criteria included articles that addressed the PICOT question. This
included PrEP screening, PrEP prescribing, full text, and peer-reviewed. Age, sex, ethnicity, and
sexual orientation were not eliminated from inclusion. Exclusion criteria included non-English
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speaking literature, did not contain components of the PICOT question, and were over 10 years
old.
Evidence Search Results
Pre-exposure prophylaxis (PrEP) for the prevention of HIV is a major topic in research
and healthcare over the last ten years. However, there is not a lot of research on screening nor
ways to increase the prescription of PrEP. As stated above, Google Scholar and the USAHS
library were the preferred search tools. In the USAHS library, the professional research inquiries
were under EBSCOhost, PubMed, ProQuest, and CINAHL. A general search of citations
rendered over ten thousand results; however, this was prior to implementation of the restrictions
of peer reviewed research and a publication time frame of 2010-2021. Once those guidelines
were implemented, the number was still over eight thousand results, however only twenty-nine
were relevant to PrEP use. Once the DNP student evaluated the articles and compared them to
the PICOT question only twelve were relevant. See Figure 1 for a PRISM diagram of the search
process.
The twelve research articles selected were all evaluated by the DNP student based on the
Johns Hopkins EBP Model. The JHEBP Model has five evidence levels based on the type of
evidence and three levels based on quality. Ten of the articles were not literature reviews and
were all graded based on these levels. The articles that contained experimental, prospective
cohort studies, and intervention cohort studies were ranked level I and grade high on the JHEBP
Model. Level I is the highest level on the hierarchy of evidence guide. High quality grade is the
highest ranking on the JHEBP Model research evidence appraisal tool. According to Dang et al.
(2022), the high-quality grade is associated with research containing sufficient sample size,
thorough evidence, and consistent and definitive conclusions. The articles that were survey,
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interview, and quasi-experimental were ranked level II on the hierarchy of evidence guide. The
quasi-experimental articles were high quality grade; however, the articles that contained surveys
and interviews were considered good quality grade. According to Dang et al. (2022), the good
quality grade is research containing more reasonably consistent conclusions and results when
compared to high quality. None of the articles selected ranked levels III-V nor were they low
quality. See Appendix A. There were two systematic reviews that were determined to be
relevant. One was a quality high, while the other was quality good. The higher quality article
was directly correlated with the PICOT question compared to the good quality article. See
Appendix B for Summary of Systematic Reviews (SR).
Themes with Practice Recommendations
PrEP Screening Tool
PrEP use is known to decrease the spread of HIV; however, many are not utilizing this
great tool. Females often lack this resource compared to men. It is estimated that roughly 5 out
of 100,000 HIV positive patients in the United States were women. Of the 225,500 females who
qualify for PrEP, only 14,700 were prescribed PrEP (Martinez & Waryold, 2022). Yumori et al.
(2021) found that men (17%) were more often screened for PrEP use compared to women (1.1%)
and women were mostly educated about birth control and condoms. Utilizing a simple PrEP
screening questionnaire can be more functional than long questionnaire PrEP assessments,
especially in youth and younger adults. Labossier et al (2021) found that narrowing a
questionnaire down to relevant questionnaires from a 23-question screening tool can be utilized
to properly assess for PrEP use. These questions mostly pertained to sexual history but also
added intravenous drug use behavior as well (Labossier et al., 2021).
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Assessing for the use of PrEP can be embarrassing for the patient. Offering different
assessment platforms can be beneficial to increasing the use of PrEP. John et al. (2020) found
that 30% of the population surveyed felt more comfortable assessing the use of PrEP
electronically compared to the 19% in-person comfort levels, and 50% were comfortable in
either platform. Patient perception of risk factors can also affect their willingness to use PrEP.
Wilton et al. (2016) found that 64% of their studied population were high risk for HIV and
candidates for PrEP. However, only 16% were considered optimal candidates because they rated
high HIV risk, viewed themselves as moderate-high HIV risk, and agreed to take PrEP. Offering
different platforms to PrEP screening can help increase the use of a PrEP tool, thus increasing
prescribing of PrEP.
High Risk Sexual Behavior
Individuals with risky sexual behavior are the top population associated with the spread
of HIV. Female sex workers and individuals with multiple sex partners are among those with
risky sexual behaviors. The HIV status of partners is usually unknown. These women are also
abused sexually. Increase PrEP use among this population can help decrease the spread of HIV,
however it needs to be beneficial to them as their lifestyle is often very mobile (Becquet et al.,
2021). The authors of the study found that access to mobile and physical clinics was important
in PrEP utilization in this population. Mobile clinics would be in the form of mobile medical
units as well as standstill or physical clinics. Increasing PrEP screening in other high risk sexual
patient populations, other than men who have sex with men, will increase the uptake of PrEP in
high-risk populations.
Intravenous Drug Abuse
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Intravenous (IV) drug abuse is associated with many transmittable diseases, including
HIV and Hepatitis C. Although IV drug abuse is a risk factor for HIV, it is often also associated
with high-risk sexual behavior. According to Johnson et al. (2022), prior to 2020, the use of
PrEP was not assessed in IV drug users or patients receiving medications for opioid abuse
(MOUD). Picard et al. (2020) found that there was not a tool that specifically and accurately
assesses IV drug users for the use of PrEP. Utilization of the CDC screening tool only
determined 39% were eligible for PrEP, whereas 71% were eligible with the assessing for risk of
contracting HIV (ARCH-IDU) tool. Combining both tools did determine that 89% of IV drug
users were eligible for PrEP (Picard et al., 2020). Johnson et al. (2022) also found that 59% of
patients assessed for PrEP were eligible with both tools, compared to 18% just based on sexual
behaviors and 9% based on IV drug use. Goldstein et al. (2020) also found that at least 38% of
adults who received treatment for substance abuse disorder (SUD) were at high risk for HIV and
were good candidates for PrEP use. PrEP screening should be implemented in SUD/MOUD
treatment facilities and clinics to increase the use of PrEP in high-risk IV drug abusers.
HIV PrEP use has been shown to be beneficial in the prevention of HIV for patients at
high risk. Although men who have sex with men are the highest risk for HIV and are more often
screened for the use of PrEP, other patients are also at risk and need to be screened frequently.
Offering screening options can be beneficials to those who do not feel comfortable answering
questions in person. Bringing screening to patients via mobile units can also help reach transient
patients who are not able to go to physical clinics. Lastly, collaborating with other healthcare
clinics, such as SUD treatment centers, can also help increase screening for IV drug users during
treatment. There are numerous ways to increase HIV PrEP screening and can decrease the
spread of HIV.
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Setting, Stakeholders, and Systems Change
Setting
This evidence-based practice implementation project took place at a Kansas City
Federally Qualified Healthcare Center (FQHC). This FQHC facility provides care for roughly
40,000 patients each year from at least five counties in the Kansas City Missouri and Kansas
populous. There are a total of nine facilities in the organization. This organization provides
numerous specialized care: adult medicine, pediatrics, family medicine, dental, optometry,
behavioral health, women’s health, and mobile units that are dedicated to the homeless
population. Most of the population served are low income, uninsured, undocumented, and/or
homeless. This FQHC facility mission statement is improving “the health and wellness of the
community by delivery of accessible, quality, comprehensive patient care,” (Swope Health,
2022).
This organization currently treats hepatitis C patients; however, there is no treatment for
HIV other than testing. Less than ten patients receiving care at this organization are currently
receiving pre-exposure prophylaxis (PrEP) treatment, however most of the patient population
being cared for qualify for PrEP. This organization provides care based on quality measures.
These measures are HIV screening and the provision of care for prevention and treatment. This
measure was not currently being met adequately, which led to the establishment of this
organizational need. This project implementation took place at one clinic within the
organization.
Stakeholders
There are several external and internal stakeholders that were associated with the project.
Internal stakeholders included the Chief Quality Officer, Chief Outreach Officer (also preceptor),
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medical assistant in outreach clinic, registered nurse in outreach clinic, Chief Medical Officer,
senior leadership team, and nurse practitioner in outreach. External stakeholders included
patients, local HIV organization supplying HIV screening tools, local government payers and/or
insurance agencies. These individuals or organizations worked directly or indirectly to help
initiate this project.
Systems Change
This evidence-based implementation project was a meso system change. The meso
system was a connection between different micro systems that helped with the continuum of care
(Likosky, 2014). The micro systems in this project were the patients at high risk for HIV and
prescribed PrEP. The connection, or meso system, that connected the two was the provider
screening for PrEP. Uniting these micro systems into one unit (meso system) helped keep
patients from contracting HIV as included education on safe practices.
The evidence-based implementation project was the beginning of changing HIV practice
in this facility. After implementing the PrEP screening tool and increasing PrEP prescribing, the
organization plans to expand to treatment of HIV+ patients. Utilizing the strengths, weaknesses,
opportunities, or threats (SWOT) analysis assisted in formulating a plan for success. This FQHC
facility already has several strengths and opportunities associated with the project, such as the
patient population it serves and the strategic locations of all clinics. Weaknesses associated with
this project and organization were the implementation process itself and limited amount of
knowledge within the organization. Threats included the numerous competitive organizations in
the area. See appendix D for SWOT analysis.
Implementation Plan with Timeline and Budget
Project Objectives
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Specific, measurable, attainable, realistic, and timed (SMART) objectives were essential
in the implementation process of this project. There are several objectives that were
implemented to keep outcomes achievable. Presentation of the project was given to the senior
leadership of the organization (See Appendix E for PowerPoint Presentation for Organization).
Prior to implementation, the providers and medical assistants in the selected clinic were given an
in-service by the project manager with the utilization of a power point and a copy of the PrEP
screening tool (See Appendix F for PowerPoint Presentation for Clinic). These individuals were
then given a questionnaire to determine their understanding of the content (See Appendix H
Post-training Questionnaire). The DNP student checked in with the selected clinic every week to
determine the screening tool was being utilized frequently and if there were any staff questions
and/or concerns needing addressed. Screening for PrEP did not only identify patients that would
benefit from PrEP, but it also educated patients on the importance of HIV prevention and start
the conversation on the risks of HIV and benefits of PrEP. Now that the eight-week
implementation phase is completed, the screening tool can be utilized to all high-risk patients
and can be implemented throughout the organization.
The PrEP screening tool (See Appendix G for the tool) was built based on the Columbia
University global health initiative to assist providers in screening for the use of PrEP. The
screening tool was initiated in 2019 as a clinical trial called PC4PrEP: Integrating PrEP into
Primary Care. This clinical trial was developed and piloted in primary care located in Federally
Qualified Health Centers (FQHC). This tool was developed to be easily utilized in the United
States and other countries (Bauman, 2020). The organization developed a program, ICAP PrEP
Package, to assist organization all over the world to implement PrEP. The program is a training
curriculum, screening tool, and PrEP prescribing tool. The organization describes the package as
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a foundation that can be adapted to any facility. The package contains numerous guides for
participants, facilitators, and trainers. The PrEP package has numerous guides that include step
by step processes for training every individual involved in implementing a PrEP screening tool,
including the trainer themselves. The package is offered in numerous languages including
English, Russian, Spanish, French, and Portuguese. The introduction manual gives permission
for the package to be utilized by any organization (ICAP, 2022).
The objectives of the project included the following. Understanding of the PrEP
screening tool that took place prior to implementation by educating providers and medical
assistants during an in-service regarding education and implementation. The goal of the project
was to see the PrEP screening tool was given to at least 70% of patients’ high risk for HIV and to
see an increase of at least 15% of PrEP prescribing. According to the tool, if a patient answers
yes to any of the risk questions and they are currently negative for HIV or have not had an
exposure in the last two weeks they are eligible for PrEP. Ultimately, the decision to prescribe
PrEP was between the provider and the patient. The PrEP screening tool was beneficial to the
clinic by the end of the eight-week implementation phase by showing an increase in screening,
education, and PrEP prescribing, therefore it will be adopted by the organization for all clinics.
The tool did not contain any identifying information that would compromise HIPAA.
Once the PrEP tool was given, the patient was determined to be at risk and was subsequently
educated on the use of PrEP. There are four areas that were considered a positive screening: if
the patient answered “yes” to any of the at-risk questions, no signs of active HIV, negative HIV
lab test, and a glomerular filtration rate (GFR) of over 60. If the patient agreed to starting PrEP,
there were a set of labs that were assessed prior to implementing PrEP: a 4th generation HIV test
and a metabolic panel to assess kidney function (See Appendix J for PrEP Eligibility). The
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kidney function assessment is necessary due to the risks of taking either of the two oral PrEP
medications that are currently available. The medications were Truvada and Descovy; both have
implications to specific kidney functions. Truvada is more readily utilized because it is FDA
approved in all patients (Columbia University, 2022). Standard sexually transmitted labs were
also drawn. This included syphilis, hepatitis, chlamydia, and gonorrhea (oral, rectal, and
genitourinary).
Implementation Plan
The Johns Hopkins evidence-based practice model for practice “evidence, translation
(PET) process” guide is a step-by-step guide to develop and implement an EBP project. There
are three sections to this process: practice question and project planning, evidence, and
translation. Each section has numerous steps. The implementation phase of this project was in
the translation section, step six, which is the implement action plan step (Dang et al, 2022). The
implementation of this project plan incorporated Havelock’s Model of Change. There are six
steps to this model: building a relationship, diagnosing the problem, acquiring resources for
change, selecting a solution pathway, establishing and accepting change, and maintenance
(Wagner, 2018). Each of these steps will depict a process of the plan from beginning to end and
incorporate aspects of the PET process. See timeline in Table 1.
Building a Relationship
Phase one of the change model was building a relationship. In this phase, the project
manager determined if there was an area in the organization that needed a change. During this
phase, the DNP student worked along with members of the organization to discuss possible areas
of improvement. HIV prevention is an area that needed positive change within this organization,
specifically with use of PrEP. Working alongside the chief medical/quality officer and the

PRE-EXPOSURE PROPHYLAXIS (PREP) SCREENING TOOL

18

outreach manager, helped to determined that this area should be utilized as the EBP project. This
phase of the process also incorporated steps one and two in the practice question and project
planning. Step one was to recruit interprofessional organizational team and step two was to
determine leadership responsibility (Dang et al., 2022).
Diagnosing the Problem
Phase two of the change model was diagnosing the problem. The problem was limited
PrEP utilization for HIV prevention. PrEP is an evidence-based HIV prevention medication that
is very successful, however prescribing is lacking according to numerous research claims.
Evidence has shown that screening for HIV risk can help the uptake of PrEP use. During
multiple team meetings, and grant meetings, it was concluded that the first step was increasing
screening. This was also when the budget plan will be documented (See figure 1). Steps three
through seven discussed the problem, identified the question, need for the project, stakeholders,
and meetings (Dang et al., 2022).
Acquiring Resources for Change
Phase three of the change model was acquiring resources for change, or the evidence that
had already been established. Searching for evidence that matches the PICOT question, as well
as determined the best evidence-based results regarding the use of screening tools for PrEP had
taken place in the phase. Eliminating research that does not pertain and selecting the best
evidence that matched was very imperative to have a successful project. This phase of the model
incorporated all the second section of the PET process (Evidence) and steps eight through twelve
which was researching and selecting the best evidence (Dang et al., 2022).
Selecting a Solution Pathway
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Phase four of the change model was selecting a solution pathway. This was the
implementation phase of the project. Prior to implementation, there was staff education
regarding the importance of the project and the screening tool that was utilized on high-risk HIV
patients. An hour in-service took place in person with a power point presentation. The power
point educated, briefly, on HIV and the need for prevention. The PrEP screening tool was
introduced and discussed. The ending of the in-service was a question-and-answer session with
a survey at the end regarding knowledge and barriers. A week after the in-service was the
implementation of the screening tool in the selected clinic. Each week the project manager
checked in with the staff regarding the utilization of the tool, if PrEP was being prescribed, and
answered any questions/concerns in the clinic. Surveys were initially kept in a lock box that was
kept in the providers office and monitored weekly during the check-ins. This phase was part of
the PET translation phase and incorporated steps thirteen through sixteen when education and
implementation took place (Dang et al., 2022).
Establishing and Accept Change
Phase five of the change model was establishing and accepting change. This was when
the results of the implementation were evaluated. This was determined if the screening tool was
successful in increasing PrEP prescription. The results were documented using statistical
analysis and presented to the organization and stakeholders. If the positive results are accepted
by the organization and stakeholders, the implementation of this tool will be utilized in other
clinics within the organization. This phase is part of the PET translation phase and incorporates
steps seventeen through nineteen (Dang et al., 2022).
Maintenance
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The last phase of the change model is maintenance. This is when the screening tool will
be implemented throughout the organization and dissemination of the findings take place. This
can also be where growth from the original project can start. This also incorporates the last step
of the translation phase (Dang et al., 2022).
Budget
The budget utilized in this project was referring to the eight-week period. There was
expenses and revenue. Expenses were divided into direct and indirect. Direct expenses consisted
of salaries, supplies, services, and labs. Most of the direct expenses were coming from salaries
associated with staff and provider. Indirect expenses consisted of overhead such as paper, pens,
electricity, etc. that was used for everyday productivity. Revenue consisted of billing that took
place with every patient and grants that were obtained. Total expenses were deducted from total
revenue and concluded a positive net balance. See Figure 2 for the Budget.
Results
Evaluating the outcome of this project consisted of patients prescribed PrEP for
prevention of HIV. The population that was utilized in this project was anyone, over the age of
18, that was considered high risk for HIV and answered the screening tool positively. The
inclusion population of patients included men who have sex with men, intravenous drug users,
individuals with multiple sexual partners, and/or sex workers. Most patients seen daily were
considered high risk for HIV. The exclusion population were those who are not considered high
risk for HIV or under the age of 18. The outcome of the PICOT question was achieved by an
increase in the prescribing of PrEP throughout the clinic during an eight-week period.
Prior to the implementation of the project, staff and providers in the clinic were educated
on the purpose of the project, as well as the general organization. The leaders of the organization
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were educated via a PowerPoint presentation regarding the reasoning for the project (see
Appendix E). A week prior to the implementation of the project, the clinic staff and providers
were also educated via a PowerPoint presentation (see Appendix F). After the presentation and
questions were answered, the group was given a questionnaire rating their satisfaction with the
presentation and understanding of the project (see Appendix H). Three staff members and one
provider were available for the presentation and questionnaire. The questionnaire consisted of
eight questions that were to be ranked from 5 (very satisfied) to 1 (very unsatisfied). For the
question “How satisfied are you with the training?”, two attendees ranked the presentation 5 and
two ranked the presentation 4. For the question “Do you have a better understanding of HIV?”,
all attendees ranked the presentation 4. For the question “Do you have a better understanding of
the PrEP screening tool?”, three attendees ranked the presentation 5 and one attendee ranked the
presentation 4. For the question “Do you feel this tool will hinder your workflow?”, all attendees
ranked the presentation 5. For the question “Do you feel you will be complaint with the tool
implementation?”, all attendees ranked the presentation 5. For the question “Do you feel
comfortable giving the tool to patients?”, two attendees ranked the presentation 5, one ranked the
presentation 4, and one ranked the presentation 3. For the question “Do you feel you can
identify patients’ high risk for HIV?”, one attendee ranked the presentation 5 and three ranked
the presentation 4. For the question “Was this presentation beneficial to you?”, all attendees
ranked the presentation 5. Most questions were answered with a 5 (very satisfied) or 4 (mostly
satisfied).
Data that was collected throughout the project was the utilization of the PrEP screening
tool and an increase in prescribing of PrEP. The PrEP screening tool, or questionnaires, were
collected by clinic provider and placed in a locked box. The locked box was stored in the clinic
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providers office, which was always locked. The clinic provider placed a note on the
questionnaire to inform if PrEP was prescribed. If the patient did not complete the screening
tool, that information was not included in the results. Once a week the project manager collected
the questionnaires from the locked box and logged the results on an Excel spreadsheet as well as
PrEP prescribing. Only two individuals handled the questionnaires, the project manager and
clinic provider. No names or identifying information were placed on the questionnaires. No
electronic records were utilized in this project.
Data was compared to PrEP screening that was being used prior to the implementation of
the PrEP screening tool. The organizations IT department retrieved data electronically to
determine how many patients were being screened for PrEP and how many patients were being
prescribed PrEP. In the eight weeks pre-implementation there were a total of 13 patients who
were screened, and 5 patients were prescribed PrEP. This is roughly 3% of patients seen.
During the eight weeks of implementation a total of 305 patients, out of 448, were screened and
13 were prescribed PrEP. This amounts to 68% of patients that were seen qualified for
screening. Sixty-eight percent did not meet the 70% objective; however, it did increase the
amount screened by 65% which is significant. Although the number of those screened did have
a significant increase, those prescribed PrEP did not see a significant increase. Preimplementation saw 38% of those screened prescribed PrEP, whereas post-implementation saw
2% of those screened prescribed PrEP. The data retrieved from pre- and post-intervention was
measured with an unpaired t-test because it is comparing two unfamiliar interventions at
different times. Intellectus statistics was utilized for the results to assist in determining
significance. A two-tailed independent t-test was conducted to examine whether the mean of
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screened patients was significantly difference from the patients prescribed PrEP pre- and postintervention.
Shapiro-Wilk tests were conducted to determine whether screened patients could have
been produced by a normal distribution for each category of PrEP prescription (Razali & Wah,
2011). The result of the Shapiro-Wilk test for screened patients not prescribed PrEP category
was significant based on an alpha value of .05, W=0.70, p=.002. This result suggests that
screened patients in the not prescribed PrEP category is unlikely to have been produced by a
normal distribution. The result of the Shapiro-Wilk test for screened patient in the prescribed
PrEP category was significant based on an alpha value of .05, W=0.77, p=.031. This result
suggests that screened patients in the prescribed PrEP category is unlikely to have been produced
by a normal distribution. The Shapiro-Wilk test was significant for both the not prescribed and
prescribed PrEP categories, indicating the normality assumption is violated.
Levene’s test was conducted to assess whether the variance of screened patients was
equal between prescribed and not prescribed PrEP. The result of Levene’s test was screened was
not significant based on an alpha value of .05, F(1, 13) = 0.30, p= .595. These results suggest it
is possible that the variance of screened is equal for each category of prescribed or not prescribed
PrEP, indicating the assumption of homogeneity of variance was met.
The result of the two-tailed independent samples t-test was not significant based on an
alpha value of .05, t(13) = -1.78, p=.098, indicating the null hypothesis cannot be rejected. This
finding suggests the mean of screened patients was not significantly different between prescribed
and not prescribed categories. The results are presented in Appendix I. A bar plot of the means
is presented in Figure 3.
Impact
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Pre-exposure prophylaxis (PrEP) is a daily medication that can be taken to prevent HIV.
Prior to the implementation of the project, HIV prevention was not accurately addressed at the
implementation facility. Although HIV is very easily prevented, there was not routine screening
for HIV risk factors. With the implementation of this project, a screening tool was introduced to
easily screen for the need of PrEP in patients’ who are high risk for HIV. Prior to the
implementation, there were three patients utilizing PrEP. After implementation, 13 out of 305
patients screened were prescribed PrEP. Although this was only a 2% prescription rate, there
were many more patients screened for the risk of HIV and educated on the use of PrEP.
Education is a key aspect of any change and increasing the education of PrEP could lead to
increase usage in the future. The screening tool was not a hinder to clinic flow and was easily
filled out by patients for the provider to discuss during the visit.
This evidence-based project implementation was a pilot for this organization. It was
implemented in one clinic to determine if it was successful and then subsequently to utilize in all
clinics. While the percentage increase of those prescribed PrEP before and after the educational
intervention was not significant, the implementation of the tool was successful with increasing
education and the understanding the HIV prevention. It was easily utilized by all involved and
did not disrupt clinic time. There was no need for additional education. Additional funding may
be needed in the future for purposes of PrEP navigators to help ensure patients take their
medication properly and come in for appointments. The organization did recently receive
funding for the prevention of HIV and screening for PrEP. Going forward, the IT department
will monitor the use of the PrEP screening tool for the facility quality department and share the
results quarterly. Advertising PrEP and HIV prevention using brochures or posters in the clinic
rooms could also increase education on the subject and intrigue patients to ask.
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Limitations included a small population size. The use of one clinic, that is not as busy as
others, did result in a smaller population of patients screened. The small amount of time for the
implementation was also a limitation. Eight weeks was not long to collect a large population
size. A lack of patient education on the topic prior to implementation may also be seen as a
barrier. Many patients in this organization have not been educated on HIV risks and factors to
prevent. Stigma associated with HIV, even HIV prevention, initially prevents many from taking
PrEP. Continued education will eventually lead to more prescribing of PrEP.
Dissemination Plan
Dissemination will be conducted in numerous ways. Results will be presented to the
implementation facility in two sections. The first presentation will take place for the senior
leadership team and stakeholders. This will also include all those involved in the
implementation: nurses, medical assistants, and Director of Outreach services. The presentation
will be in form of a PowerPoint. The next presentation will include the medical providers.
During the monthly provider meeting, the same PowerPoint presentation will be given on the
nature of the PrEP screening tool and the results that were obtained during the implementation.
Results also plan to be presented at the National Nurse Practitioner Symposium or the American
Association of Nurse Practitioner (AANP) National Conference as a poster presentation. The
professional journal, AIDS Education & Prevention: An Interdisciplinary Journal, focuses on
AIDS education and prevention. This journal would be ideal for preventing HIV with the use of
a PrEP screening tool. The results will be submitted as a peer-review manuscript.
Sharing results of the project is very important to keep the subject moving forward and
advancing. Presenting to a smaller group will include PowerPoint of the purpose of the project
and the results found. Those involved in the project will be invited to attend a virtual
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presentation. Dissemination plans for a larger group, such as the AANP National Conference,
will be presented via poster board presentation. Presenting at a national conference will give
opportunities to discuss with professionals in this area of nursing and reach naïve family practice
that does not currently prescribe PrEP. HIV Specialist is a publication associated with HIV care
providers and challenges faced in the prevention and treatment of HIV. This research
manuscript will be peer-reviewed and submitted to the HIV Specialist. These presentations will
be assessed to continuing the fight of prevention HIV.
Conclusion
Human immunodeficiency virus (HIV) is a global pandemic that is very preventable with
the use of pre-exposure prophylaxis (PrEP), however it is not being utilized as much as it can be.
Implementing a PrEP screening tool to identify patients at high risk for HIV is essential to
preventing HIV. Those high risk for HIV include men who have sex with men, sex workers,
individuals with multiple sex partners, and intravenous drug users. Federally qualified health
centers (FQHC) often care for patients in this risk. A FQHC facility clinic implemented the
PrEP screening tool for the increase of PrEP prescribing. Leadership and stakeholders will be
presented with the implementation project. Once accepted, clinic personal will be educated on
the tool and the importance of implementation. There will be a 70% success rate in utilizing the
screening tool and a 15% increase in the prescribing of PrEP within an eight-week period. The
PrEP screening tool will show success and be adopted into use across the organization.
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Figure 2
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Figure 3
The mean of screened patients by levels of PrEP prescribed with 95.00% CI Error Bars
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were eligible for no data regarding that
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start of PrEP and
follow-up.
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HIV prevention.

There were
numerous barriers
found that affected
PrEP
implementation.
These include
patient and provider
barriers.

While this
research is not
directly
associated with
the PICOT
question, it does
address barriers
to facilitating
PrEP screening.
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Appendix C
Project Schedule

preceptor
Prepare project

X

proposal
Present to

X

Organization
Senior Leadership
Educate clinic on

X

project and
implementation
Survey clinic for
understanding

X

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

NUR7803

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

X

NUR7802

Week 5

Week 1

Meet with

Week 3

Activity

NUR7801
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day
Weekly check-in
with clinic
Weekly collection
of data
End

X

implementation
Record all

X

finalized results
Present results to

X

clinic
Present results to
organization
leadership and

X

Week 15

Week 13

Week 11

Week 9

X

X

Week 7

X X

Week 5

X

Week 3

X

Week 1

X X

Week 15

X

Week 9

Week 13

NUR7803

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

NUR7802
Week 11

Implementation

Week 1

Activity

NUR7801
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project of
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stakeholders

X

Week 15
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Week 11

Week 9

Week 7

Week 5

Week 3
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Week 1

Week 15
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Week 11

Week 9

Week 7

Week 5

Week 3
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Week 1
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Week 1
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PowerPoint Presentation for Organization
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Appendix F
PowerPoint Presentation for Clinic
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Appendix G
PrEP Screening Tool
Patient Demographics

Circle you answer or fill in

What was sex at birth?

Male

Female

Other:____________

What is your current gender?

Male

Female

Transgender (male to female)

Transgender (female to male)
Age?

Other:____________

Number:__________

Screening questions to determine risk for HIV infection
Have you been sexually active in the last six months?
How many partners have you had vaginal or anal sex in
the last six months?
In the last six months did you use condoms consistently?

Circle your answer or fill in
Yes
No
Number________
Yes

No

Have you had a sex partner in the last six months who:
• Living with HIV?
• Injects drugs?
• Has sex with men?
• Is a transgender person?
• Sex worker?
• Has sex with multiple partners without condoms?

Answers:
Yes
Yes
Yes
Yes
Yes
Yes

No
No
No
No
No
No

Have you had a STI in the last six months?

Yes

No

Have you ever taken post-exposure prophylaxis (PEP)?

Yes

No

Have you shared injecting materials with other people?

Yes

No

Is your partner HIV positive?

Yes

No
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Appendix H
Post-training Questionnaire
Question

5

4

3

2

1

How satisfied are you with the training?
Do you have a better understanding of HIV?
Do you have a better understanding of the PrEP
screening tool?
Do you feel this tool will hinder your workflow?
Do you feel you will be complaint with the tool
implementation?
Do you feel comfortable giving the tool to patients?
Do you feel you can identify patients’ high risk for HIV?
Was this presentation beneficial to you?
5: very satisfied. 4: somewhat satisfied. 3: neutral. 2: somewhat unsatisfied. 1: very unsatisfied

Comments:
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Appendix I
Variable Table
Two-Tailed Independent Samples t-Test for screened patients by prescribed PrEP
N
Variable

M

Y
SD

M

SD

t

p

Screened
13.44
18.04
32.83
24.24
-1.78
.098
Note. N = 15. Degrees of Freedom for the t-statistic = 13. d represents Cohen's d.

d
0.91
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Appendix J
PrEP Eligibility
Eligible if ALL criteria below are met:

For provider:

HIV-negative

At risk for HIV

Date tested:
Date test received:
Result:
Type of test:
At least one item from risk questions

Has no signs/symptoms of acute HIV

No recent exposures

Has a GFR >60

GFR Result/Date:
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